FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johann Wojta

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Disorders

Procedures

Enzyme-Linked Immunosorbent Assay

Co-author Network

Publications

TOP 3
A Piechota-Polanczyk; Johann Wojta; Svitlana Demyanets; Christoph Domenig; Ihor Huk; Martina Mittlboeck; Josif Nanobachvili; Christoph Neumayer; O Nykonenko; M Klinger
Decreased Tissue Levels of Cyclophilin A, a Cyclosporine A Target and Phospho-ERK1/2 in Simvastatin Patients with Abdominal Aortic Aneurysm.
Stefan Pfaffenberger; E Unger; E Vyskocil; C Woeber; Michael Gottsauner-Wolf; K Huber; Stefan Kastl; Christoph Kaun; Christian Kollmann; G Maurer; G Nawratil; Johann Wojta
Transtemporal ultrasound application potentially elevates brain temperature: results of an anthropomorphic skull model.
Johann Wojta
Factor XIII and alternatively activated macrophages - new targets in aortic valve stenosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johann Wojta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Piechota-Polanczyk; Johann Wojta; Svitlana Demyanets; Christoph Domenig; Ihor Huk; Martina Mittlboeck; Josif Nanobachvili; Christoph Neumayer; O Nykonenko; M Klinger
Decreased Tissue Levels of Cyclophilin A, a Cyclosporine A Target and Phospho-ERK1/2 in Simvastatin Patients with Abdominal Aortic Aneurysm.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2013;45(6):682-8.
2013: Stefan Pfaffenberger; E Unger; E Vyskocil; C Woeber; Michael Gottsauner-Wolf; K Huber; Stefan Kastl; Christoph Kaun; Christian Kollmann; G Maurer; G Nawratil; Johann Wojta
Transtemporal ultrasound application potentially elevates brain temperature: results of an anthropomorphic skull model.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2013;34(1):51-7.
2012: Johann Wojta
Factor XIII and alternatively activated macrophages - new targets in aortic valve stenosis.
Thrombosis and haemostasis 2012;108(6):1023.
2012: Bernhard Richter; Kathrin Rychli; Johann Wojta; Gerlinde Zorn; Richard Pacher; Rudolf Berger; Georg Goliasch; Philipp J Hohensinner; Kurt Huber; Martin Hülsmann; Lorenz Koller; Gerald Maurer; Deddo Mörtl; Alexander Niessner
Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
Thrombosis and haemostasis 2012;108(6):1220-7.
2012: E Vyskocil; Johann Wojta; K Aumayr; Andreas Gleiss; K Huber; Stefan Kastl; Christian Kollmann; G Nawratil; Stefan Pfaffenberger; Othmar Schuhfried; E Unger; Michael Gottsauner-Wolf
Thermal effects of diagnostic ultrasound in an anthropomorphic skull model.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2012;33(7):E313-20.
2012: Matthias K Freynhofer; Miloš Tajsić; Johann Wojta; Kurt Huber
Biomarkers in acute coronary artery disease.
Wiener medizinische Wochenschrift (1946) 2012;162(21-22):489-98.
2012: Svitlana Demyanets; Kurt Huber; Johann Wojta
Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets.
Vascular pharmacology 2012;57(1):29-40.
2012: A Piechota-Polanczyk; Johann Wojta; Martina Mittlboeck; Josif Nanobachvili; Christoph Neumayer; Svitlana Demyanets; Christoph Domenig; A Goraca; Ihor Huk; M Klinger
Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2012;44(2):133-7.
2012: Serdar Farhan; Gabriele Jakl-Kotauschek; Rudolf Jarai; Alexandra Kautzky-Willer; Eslam Samaha; Peter Smetana; Ioannis Tentzeris; Johann Wojta; Kurt Huber
Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease.
Clinical research in cardiology : official journal of the German Cardiac Society 2012;101(8):625-30.
2012: Georg Goliasch; Matthias Hoke; Kurt Huber; Gerald Maurer; S Oravec; Martin Schillinger; Hermann Blessberger; Elisabeth Dostal; Johann Wojta; Franz Wiesbauer
Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).
European journal of clinical investigation 2012;42(6):631-6.
2012: Georg Goliasch; Kurt Huber; Stefan Kastl; Katharina M Katsaros; Gerald Maurer; Martin Schillinger; Franz Wiesbauer; Johann Wojta; Hermann Blessberger; Walter S Speidl
Premature myocardial infarction is associated with low serum levels of Wnt-1.
Atherosclerosis 2012;222(1):251-6.
2012: Katherine R Heberlein; Angela K Best; Jenny Han; Christoph Kaun; Adam C Straub; Johann Wojta; Brant E Isakson
A novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(5):1271-9.
2012: Bernhard Richter; Ariel Socas; Johann Wojta; Gerlinde Zorn; Sulaima Albinni; Jutta Bergler-Klein; Thomas Binder; Marianne Gwechenberger; Manfred Marx; Heinz D Gössinger
Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.
Clinical research in cardiology : official journal of the German Cardiac Society 2012;101(3):217-25.
2012: Svitlana Demyanets; Johann Wojta
Sex differences in effects and use of anti-inflammatory drugs.
Handbook of experimental pharmacology 2012;(214):443-72.
2012: Matthias K Freynhofer; Veronika Bruno; Johann Wojta; Kurt Huber
The role of platelets in athero-thrombotic events.
Current pharmaceutical design 2012;18(33):5197-214.
2012: Svitlana Demyanets; Kurt Huber; Johann Wojta
Vascular effects of glycoprotein130 ligands--part I: pathophysiological role.
Vascular pharmacology 2012;56(1-2):34-46.
2011: Thomas W Weiss; Johann Wojta; Marius Trøseid; Harald Arnesen; Elsa M Hjerkinn; Kurt Huber; Christoph Kaun; Ingebjorg Seljeflot
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose.
Wiener klinische Wochenschrift 2011;123(21-22):650-4.
2011: Bernhard Richter; Ariel Socas; Johann Wojta; Florian Wolf; Gerlinde Zorn; Sulaima Albinni; Jutta Bergler-Klein; Christian Bieglmayer; Thomas Binder; Marianne Gwechenberger; Christian Loewe; Manfred Marx; Heinz D Gössinger
Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome.
International journal of cardiology 2011;152(2):231-6.
2011: Thomas Weiss; Kurt Huber; Christoph Kaun; Gerald Maurer; Heinz Pflüger; Gersina Rega; Rainer Simak; Johann Wojta
Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.
Anticancer research 2011;31(10):3273-8.
2011: Serdar Farhan; Matthias K Freynhofer; Ivan Brozovic; Rudolf Jarai; Alexandra Kautzky-Willer; Ioannis Tentzeris; Birgit Vogel; Thomas Wascher; Johann Wojta; Kurt Huber
Admission proinsulin is associated with mortality in patients with admission hyperglycemia during acute coronary syndrome: results from a pilot observational study.
Clinical chemistry 2011;57(10):1456-60.
2011: Matthias Hoke; Renate Koppensteiner; Gerald Maurer; Erich Minar; Wolfgang Mlekusch; Martin Schillinger; Walter S Speidl; Johann Wojta; Anna Wonnerth; Gerlinde Zorn; Jasmin Amighi; Alexander Niessner
The prognostic impact of soluble apoptosis-stimulating fragment on mortality in patients with carotid atherosclerosis.
Stroke; a journal of cerebral circulation 2011;42(9):2465-70.
2011: Svitlana Demyanets; Marion Gröger; Akos Heinemann; Kurt Huber; Ihor Huk; Stefan Kastl; Christoph Kaun; Viktoria Konya; Christof E Lemberger; Gerald Maurer; Alexander Niessner; Richard Pentz; Stefan Pfaffenberger; Sabine Rauscher; Kathrin Rychli; Rainer de Martin; Johann Wojta
Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(9):2080-9.
2011: Alexandra Schwarzmaier-D'Assie; Christoph Strehblow; Johann Wojta; Serdar Farhan; Dietmar Glogar; Mariann Gyöngyösi; Rayyan Hemetsberger; Kurt Huber; Johannes Matiasek; Noemi Nyolczas; Zsolt Petrasi; Christian Plass; Ronald Karnik
Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2011;18(4):547-58.
2011: Ioannis Tentzeris; Johann Wojta; Serdar Farhan; Gabriele Jakl; Rudolf Jarai; Thomas Perkmann; Michael A Schwarz; Kurt Huber
Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
European journal of heart failure 2011;13(7):726-33.
2011: Kathrin Rychli; Johann Wojta; Gerlinde Zorn; Rudolf Berger; Philipp J Hohensinner; Kurt Huber; Ali Kariem Mahdy; Deddo Mörtl; Stephanie Neuhold; Alexander Niessner; Richard Pacher; Bernhard Richter; Martin Hülsmann
Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Heart (British Cardiac Society) 2011;97(14):1158-63.
2011: Matthias K Freynhofer; Rudolf Jarai; Thomas Höchtl; Veronika Bruno; Birgit Vogel; Kadriye Aydinkoc; Michael Nürnberg; Johann Wojta; Kurt Huber
Predictive value of plasma Nt-proBNP and body mass index for recurrence of atrial fibrillation after cardioversion.
International journal of cardiology 2011;149(2):257-9.
2011: Philipp J Hohensinner; Alexander Niessner; Kurt Huber; Cornelia M Weyand; Johann Wojta
Inflammation and cardiac outcome.
Current opinion in infectious diseases 2011;24(3):259-64.
2011: Ioannis Tentzeris; Jolanta Siller-Matula; Serdar Farhan; Rudolf Jarai; Johann Wojta; Kurt Huber
Platelet function variability and non-genetic causes.
Thrombosis and haemostasis 2011;105 Suppl 1():S60-6.
2011: K M Katsaros; Franz Wiesbauer; Walter S Speidl; Stefan Kastl; Kurt Huber; Gerlinde Zorn; Alexander Niessner; Dietmar Glogar; Gerald Maurer; Johann Wojta
High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
Thrombosis and haemostasis 2011;105(5):883-91.
2011: Svitlana Demyanets; Christoph Kaun; Kathrin Rychli; Stefan Pfaffenberger; Stefan Kastl; Philipp J Hohensinner; Gersina Rega; Katharina M Katsaros; Taras Afonyushkin; Valery N Bochkov; Matthias Paireder; Ihor Huk; Gerald Maurer; Kurt Huber; Johann Wojta
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Basic research in cardiology 2011;106(2):217-31.
2011: Walter S Speidl; Stefan Kastl; Kurt Huber; Johann Wojta
Complement in atherosclerosis: friend or foe?
Journal of thrombosis and haemostasis : JTH 2011;9(3):428-40.
2011: Georg Goliasch; Franz Wiesbauer; Andreas Grafl; Elisabeth Ponweiser; Hermann Blessberger; Ioannis Tentzeris; Johann Wojta; Martin Schillinger; Kurt Huber; Gerald Maurer; Christine Mannhalter; Raute Sunder-Plassmann
The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age).
Thrombosis and haemostasis 2011;105(3):529-34.
2011: Georg Goliasch; Hermann Blessberger; Danyel Azar; Georg Heinze; Johann Wojta; Christian Bieglmayer; Oswald Wagner; Martin Schillinger; Kurt Huber; Gerald Maurer; Martin Haas; Franz Wiesbauer
Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age).
Bone 2011;48(3):622-6.
2011: Ioannis Tentzeris; Rudolf Jarai; Serdar Farhan; Johann Wojta; Martin Schillinger; Alexander Geppert; Michael Nürnberg; Gerhard Unger; Kurt Huber
Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: a single centre experience.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(3):191-200.
2011: Thomas Höchtl; Serdar Farhan; Johann Wojta; Kurt Huber
New anticoagulant agents in acute coronary syndromes.
Heart (British Cardiac Society) 2011;97(3):244-52.
2011: Thomas Eschenhagen; Thomas Force; Michael S Ewer; Gilles W De Keulenaer; Thomas M Suter; Stefan D Anker; Metin Avkiran; Evandro de Azambuja; Jean-Luc Balligand; Dirk L Brutsaert; Gianluigi Condorelli; Arne Hansen; Stephane Heymans; Joseph A Hill; Emilio Hirsch; Denise Hilfiker-Kleiner; Stefan Janssens; Steven de Jong; Gitte Neubauer; Burkert Pieske; Piotr Ponikowski; Munir Pirmohamed; Mathias Rauchhaus; Douglas Sawyer; Peter H Sugden; Johann Wojta; Faiez Zannad; Ajay M Shah
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
European journal of heart failure 2011;13(1):1-10.
2011: Walter S Speidl; Stefan Kastl; Randolph Hutter; Katharina M Katsaros; Christoph Kaun; Gerhard Bauriedel; Gerald Maurer; Kurt Huber; Juan J Badimon; Johann Wojta
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(1):35-44.
2010: Olga Oskolkova; Taras Afonyushkin; Beatrix Preinerstorfer; Wolfgang Bicker; Elena von Schlieffen; Eva Hainzl; Svitlana Demyanets; Gernot Schabbauer; Wolfgang Lindner; Alexandros D Tselepis; Johann Wojta; Bernd R Binder; Valery N Bochkov
Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(12):7706-12.
2010: Ioannis Tentzeris; Rudolf Jarai; Serdar Farhan; Ivan Brozovic; Peter Smetana; Alexander Geppert; Johann Wojta; Jolanta Siller-Matula; Kurt Huber
Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Thrombosis and haemostasis 2010;104(6):1211-8.
2010: Bernhard Richter; Kathrin Rychli; Philipp J Hohensinner; Rudolf Berger; Deddo Mörtl; Stephanie Neuhold; Gerlinde Zorn; Kurt Huber; Gerald Maurer; Johann Wojta; Richard Pacher; Martin Hülsmann; Alexander Niessner
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.
Atherosclerosis 2010;213(2):545-8.
2010: Kathrin Rychli; Alexander Niessner; Philipp J Hohensinner; Kariem Mahdy Ali; Christoph Kaun; Stephanie Neuhold; Gerlinde Zorn; Bernhard Richter; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Kurt Huber; Gerald Maurer; Richard Pacher; Johann Wojta
Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.
Chest 2010;138(3):656-64.
2010: Mariann Gyöngyösi; Aniko Posa; Noemi Pavo; Rayyan Hemetsberger; Heda Kvakan; Sabine Steiner-Böker; Zsolt Petrási; Ferenc Manczur; Imre J Pavo; István Ferenc Édes; Johann Wojta; Dietmar Glogar; Kurt Huber
Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion.
Thrombosis and haemostasis 2010;104(2):376-84.
2010: Kathrin Rychli; Christoph Kaun; Philipp J Hohensinner; Gersina Rega; Stefan Pfaffenberger; E Vyskocil; Johannes M Breuss; Alexander Furnkranz; Pavel Uhrin; J Zaujec; Alexander Niessner; Gerald Maurer; Kurt Huber; Johann Wojta
The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.
Journal of thrombosis and haemostasis : JTH 2010;8(3):596-604.
2010: Philipp J Hohensinner; Kathrin Rychli; Gerlinde Zorn; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Bernhard Richter; Kurt Huber; Johann Wojta; Richard Pacher; Alexander Niessner
Macrophage-modulating cytokines predict adverse outcome in heart failure.
Thrombosis and haemostasis 2010;103(2):435-41.
2010: Serdar Farhan; Thomas Höchtl; Alexandra Kautzky-Willer; Johann Wojta; Kurt Huber
Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus.
Wiener medizinische Wochenschrift (1946) 2010;160(1-2):30-8.
2010: Katharina M Katsaros; Stefan Kastl; Gerlinde Zorn; Gerald Maurer; Johann Wojta; Kurt Huber; Günter Christ; Walter S Speidl
Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
JACC. Cardiovascular interventions 2010;3(1):90-7.
2010: Walter S Speidl; Katharina M Katsaros; Stefan Kastl; Gerlinde Zorn; Kurt Huber; Gerald Maurer; Johann Wojta; Günter Christ
Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a.
Atherosclerosis 2010;208(1):285-9.
2010: Kathrin Rychli; Christoph Kaun; Philipp J Hohensinner; Adrian J Dorfner; Stefan Pfaffenberger; Alexander Niessner; Michael Bauer; Wolfgang Dietl; Bruno K Podesser; Gerald Maurer; Kurt Huber; Johann Wojta
The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts.
Journal of cellular and molecular medicine 2010;14(1-2):198-205.
2009: Kathrin Rychli; Kurt Huber; Johann Wojta
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Expert opinion on therapeutic targets 2009;13(11):1295-302.
2009: Stefan Kastl; Walter S Speidl; Katharina M Katsaros; Christoph Kaun; Gersina Rega; Afshin Assadian; Georg W Hagmueller; Martina Hoeth; Rainer de Martin; Yongsheng Ma; Gerald Maurer; Kurt Huber; Johann Wojta
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.
Blood 2009;114(13):2812-8.
2009: Ursula Hanusch-Enserer; Gerlinde Zorn; Johann Wojta; Christoph W Kopp; Rudolf Prager; Wolfgang Koenig; Martin Schillinger; Michael Roden; Kurt Huber
Non-conventional markers of atherosclerosis before and after gastric banding surgery.
European heart journal 2009;30(12):1516-24.
2009: Alexander Niessner; Philipp J Hohensinner; Kathrin Rychli; Stephanie Neuhold; Gerlinde Zorn; Bernhard Richter; Martin Hülsmann; Rudolf Berger; Deddo Mörtl; Kurt Huber; Johann Wojta; Richard Pacher
Prognostic value of apoptosis markers in advanced heart failure patients.
European heart journal 2009;30(7):789-96.
2009: Franz Wiesbauer; Hermann Blessberger; Georg Goliasch; Erik Walter Holy; Stephan Pfaffenberger; Ioannis Tentzeris; Gerald Maurer; Kurt Huber; Farshid Abdolvahab; Gottfried Sodeck; Markus Exner; Johann Wojta; Martin Schillinger
Elevated risk of myocardial infarction in very young immigrants from former Yugoslavia.
European journal of epidemiology 2009;24(11):691-6.
2008: Mariann Gyöngyösi; Jeronimo Blanco; Teréz Marian; Lajos Trón; Ors Petneházy; Zsolt Petrasi; Rayyan Hemetsberger; Julio Rodriguez; Gusztáv Font; Imre J Pavo; István Kertész; László Balkay; Noemi Pavo; Aniko Posa; Miklos Emri; László Galuska; Dara L Kraitchman; Johann Wojta; Kurt Huber; Dietmar Glogar
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression.
Circulation. Cardiovascular imaging 2008;1(2):94-103.
2008: Paul Wexberg; Nelli Jordanova; Christoph Strehblow; Bonni Syeda; Brigitte Meyer; Silvia Charvat; Gerlinde Zorn; Daniela Scheinig; Johann Wojta; Kurt Huber; Dietmar Glogar; Mariann Gyöngyösi
Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
Thrombosis and haemostasis 2008;99(4):739-48.
2008: Johann Kern; Monika Bauer; Kathrin Rychli; Johann Wojta; Andreas Ritsch; Guenther Gastl; Eberhard Gunsilius; Gerold Untergasser
Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):478-84.
2008: Stefan Kastl; Walter S Speidl; Christoph Kaun; Katharina M Katsaros; Gersina Rega; Taras Afonyushkin; Valery N Bochkov; Peter Valent; Afshin Assadian; Georg W Hagmueller; Martina Hoeth; Rainer de Martin; Yongsheng Ma; Gerald Maurer; Kurt Huber; Johann Wojta
In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):498-503.
2008: K M Katsaros; Walter S Speidl; Stefan Kastl; Gerlinde Zorn; Kurt Huber; Gerald Maurer; Dietmar Glogar; Johann Wojta; Günter Christ
Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
Journal of thrombosis and haemostasis : JTH 2008;6(3):508-13.
2008: Katharina M Katsaros; Stefan Kastl; Kurt Huber; Gerlinde Zorn; Gerald Maurer; Dietmar Glogar; Johann Wojta; Günter Christ; Walter S Speidl
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Thrombosis research 2008;123(1):79-84.
2007: Philipp J Hohensinner; Christoph Kaun; Kathrin Rychli; Alexander Niessner; Stefan Pfaffenberger; Gersina Rega; Rainer de Martin; Gerald Maurer; Robert Ullrich; Kurt Huber; Johann Wojta
Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism.
Journal of thrombosis and haemostasis : JTH 2007;5(12):2520-8.
2007: Michael Mildner; Veronika Mlitz; Florian Gruber; Johann Wojta; Erwin Tschachler
Hepatocyte growth factor establishes autocrine and paracrine feedback loops for the protection of skin cells after UV irradiation.
The Journal of investigative dermatology 2007;127(11):2637-44.
2007: Svitlana Demyanets; Christoph Kaun; Kathrin Rychli; Gersina Rega; Stefan Pfaffenberger; Taras Afonyushkin; Valery N Bochkov; Gerald Maurer; Kurt Huber; Johann Wojta
The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
American journal of physiology. Heart and circulatory physiology 2007;293(3):H1962-8.
2007: Thomas Höchtl; Linda Pachinger; Gerhard Unger; Alexander Geppert; Johann Wojta; Job Harenberg; Kurt Huber
Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reports.
Journal of thrombosis and thrombolysis 2007;24(1):59-64.
2007: Gersina Rega; Christoph Kaun; Svitlana Demyanets; Stefan Pfaffenberger; Kathrin Rychli; Philipp J Hohensinner; Stefan Kastl; Walter S Speidl; Thomas Weiss; Johannes M Breuss; Alexander Furnkranz; Pavel Uhrin; J Zaujec; V Zilberfarb; M Frey; R Roehle; Gerald Maurer; Kurt Huber; Johann Wojta
Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1587-95.
2007: Jolanta Siller-Matula; Karsten Schrör; Johann Wojta; Kurt Huber
Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Thrombosis and haemostasis 2007;97(3):385-93.
2007: Walter S Speidl; Mariam Nikfardjam; Alexander Niessner; Nelli Jordanova; Gerlinde Zorn; Gerald Maurer; Wolfgang Schreiber; Johann Wojta; Kurt Huber
Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(2):165-71.
2007: Walter S Speidl; Markus Exner; Jasmin Amighi; Wolfgang Mlekusch; Schila Sabeti; Stefan Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Complement component C5a predicts restenosis after superficial femoral artery balloon angioplasty.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2007;14(1):62-9.
2007: Rudolf Jarai; Nelly Iordanova; Robert Jarai; Ferenc Jarai; Annamaria Raffetseder; Wolfgang Woloszczuk; Mariann Gyöngyösi; Georg Geyer; Johann Wojta; Kurt Huber
Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
Wiener klinische Wochenschrift 2007;119(21-22):626-32.
2007: E Ben-Tal Cohen; Philipp J Hohensinner; Christoph Kaun; Gerald Maurer; Kurt Huber; Johann Wojta
Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro.
Biochemical pharmacology 2007;73(1):77-83.
2007: Walter S Speidl; Mariam Nikfardjam; Alexander Niessner; Andrea Zeiner; Nelli Jordanova; Gerlinde Zorn; Gerald Maurer; Wolfgang Schreiber; Johann Wojta; Kurt Huber
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Thrombosis research 2007;119(3):331-6.
2006: Alexander Niessner; Sabine Steiner; Walter S Speidl; Johannes Pleiner; Daniela Seidinger; Gerald Maurer; Jörg J Goronzy; Cornelia M Weyand; Christoph W Kopp; Kurt Huber; Michael Wolzt; Johann Wojta
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.
Atherosclerosis 2006;189(2):408-13.
2006: Thomas Weiss; Heda Kvakan; Christoph Kaun; Manfred Prager; Walter S Speidl; Gerlinde Zorn; Stefan Pfaffenberger; Ihor Huk; Gerald Maurer; Kurt Huber; Johann Wojta
No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.
Journal of clinical pathology 2006;59(11):1186-90.
2006: Valery N Bochkov; Maria Philippova; Olga Oskolkova; Alexandra Kadl; Alexander Furnkranz; Erduan Karabeg; Taras Afonyushkin; Florian Gruber; Johannes M Breuss; Alexander Minchenko; Diana Mechtcheriakova; Philipp J Hohensinner; Kathrin Rychli; Johann Wojta; Therese J Resink; Paul Erne; Bernd R Binder; Norbert Leitinger
Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions.
Circulation research 2006;99(8):900-8.
2006: Mariann Gyöngyösi; Christoph Strehblow; Wolfgang Sperker; Akos Hevesi; Rita Garamvölgyi; Zsolt Petrási; Noemi Pavo; Péter Ferdinandy; Csaba Csonka; Tamås Csont; Christer Sylvèn; Paul J Declerck; Imre Pavo; Johann Wojta; Dietmar Glogar; Kurt Huber
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.
Thrombosis and haemostasis 2006;96(2):202-9.
2006: Stefan Kastl; Walter S Speidl; Christoph Kaun; Gersina Rega; A Assadian; Thomas Weiss; Peter Valent; G W Hagmueller; Gerald Maurer; Kurt Huber; Johann Wojta
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1790-7.
2006: Philipp J Hohensinner; Christoph Kaun; Kathrin Rychli; Enbal Ben-Tal Cohen; Stefan Kastl; Svitlana Demyanets; Stefan Pfaffenberger; Walter S Speidl; Gersina Rega; Robert Ullrich; Gerald Maurer; Kurt Huber; Johann Wojta
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
FEBS letters 2006;580(14):3532-8.
2006: Alexander Niessner; Bernhard Richter; Martina Penka; Sabine Steiner; Barbara Strasser; Sophie Ziegler; Elke Heeb-Elze; Gerlinde Zorn; Angelika Leitner-Heinschink; Christina Niessner; Johann Wojta; Kurt Huber
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?
Atherosclerosis 2006;186(1):160-5.
2006: Svitlana Demyanets; Christoph Kaun; Stefan Pfaffenberger; Philipp J Hohensinner; Gersina Rega; Johannes Pammer; Gerald Maurer; Kurt Huber; Johann Wojta
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Biochemical pharmacology 2006;71(9):1324-30.
2006: Svitlana Demyanets; Christoph Kaun; Gerald Maurer; Kurt Huber; Johann Wojta
Statins modulate expression of components of the plasminogen activator/plasmin system in human cardiac myocytes in vitro.
Journal of thrombosis and haemostasis : JTH 2006;4(2):476-9.
2006: Svitlana Demyanets; Stefan Pfaffenberger; Christoph Kaun; Gersina Rega; Walter S Speidl; Stefan Kastl; Thomas Weiss; Philipp J Hohensinner; Wolf Dietrich; Walter Tschugguel; Valery N Bochkov; Ezzat M Awad; Gerald Maurer; Kurt Huber; Johann Wojta
The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway.
Thrombosis and haemostasis 2006;95(1):107-16.
2005: Thomas Höchtl; Alexander Geppert; Michael Nürnberg; Gerhard Unger; Walter S Speidl; Johann Wojta; Kurt Huber
[Direct and indirect antithrombins in acute coronary syndromes].
Wiener klinische Wochenschrift 2005;117(23-24):792-800.
2005: Bernhard Richter; Alexander Niessner; Martina Penka; Marija Grdić; Sabine Steiner; Barbara Strasser; Sophie Ziegler; Gerlinde Zorn; Gerald Maurer; Vera Simeon-Rudolf; Johann Wojta; Kurt Huber
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Thrombosis and haemostasis 2005;94(6):1306-11.
2005: Alexander Niessner; Rodrig Marculescu; Heda Kvakan; Arvand Haschemi; Georg Endler; Cornelia M Weyand; Gerald Maurer; Christine Mannhalter; Johann Wojta; Oswald Wagner; Kurt Huber
Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Thrombosis and haemostasis 2005;94(6):1251-6.
2005: Rudolf Jarai; Johann Wojta; Kurt Huber
Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations.
Thrombosis and haemostasis 2005;94(5):926-32.
2005: Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.
European heart journal 2005;26(21):2294-9.
2005: Talin Gulesserian; Catharina Wenzel; Georg Endler; Raute Sunder-Plassmann; Claudia Marsik; Christine Mannhalter; Nelly Iordanova; Mariann Gyöngyösi; Johann Wojta; Stefan Mustafa; Oswald Wagner; Kurt Huber
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
Clinical chemistry 2005;51(9):1661-5.
2005: Thomas Weiss; Heda Kvakan; Christoph Kaun; Gerlinde Zorn; Walter S Speidl; Stefan Pfaffenberger; Gerald Maurer; Kurt Huber; Johann Wojta
The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
Journal of molecular and cellular cardiology 2005;39(3):545-51.
2005: Sabine Steiner; Alexander Niessner; Sophie Ziegler; Bernhard Richter; Daniela Seidinger; Johannes Pleiner; Martina Penka; Michael Wolzt; Kurt Huber; Johann Wojta; Erich Minar; Christoph W Kopp
Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease.
Atherosclerosis 2005;181(2):305-10.
2005: Stefan Pfaffenberger; Branka Devcic-Kuhar; Stefan Kastl; Kurt Huber; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
Ultrasound thrombolysis.
Thrombosis and haemostasis 2005;94(1):26-36.
2005: Stefan Pfaffenberger; Johann Wojta; Michael Gottsauner-Wolf
High-frequency transtemporal sonothrombolysis.
Stroke; a journal of cerebral circulation 2005;36(7):1356-7.
2005: Alexander Niessner; Rodrig Marculescu; Arvand Haschemi; Georg Endler; Gerlinde Zorn; Cornelia M Weyand; Gerald Maurer; Christine Mannhalter; Johann Wojta; Oswald Wagner; Kurt Huber
Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Thrombosis and haemostasis 2005;93(5):949-54.
2005: Gersina Rega; Christoph Kaun; Thomas Weiss; Svitlana Demyanets; Gerlinde Zorn; Stefan Kastl; Sabine Steiner; Daniela Seidinger; Christoph W Kopp; M Frey; R Roehle; Gerald Maurer; Kurt Huber; Johann Wojta
Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Circulation 2005;111(15):1938-45.
2005: Sabine Steiner; Walter S Speidl; Johannes Pleiner; Daniela Seidinger; Gerlinde Zorn; Christoph Kaun; Johann Wojta; Kurt Huber; Erich Minar; Michael Wolzt; Christoph W Kopp
Simvastatin blunts endotoxin-induced tissue factor in vivo.
Circulation 2005;111(14):1841-6.
2005: Nelli Jordanova; Mariann Gyöngyösi; Aliasghar Khorsand; Christine Falkensammer; Gerlinde Zorn; Johann Wojta; Anahit Anvari; Kurt Huber
New cut-off values of cardiac markers for risk stratification of angina pectoris.
International journal of cardiology 2005;99(3):429-35.
2005: Alexander Niessner; Senta Graf; Mariam Nikfardjam; Stephan Lehr; Gerald Maurer; Johann Wojta; Kurt Huber
The adaptive immune system and long-term outcome in patients with stable coronary disease. Predictive value of routine laboratory measurements.
Thrombosis and haemostasis 2005;93(2):257-60.
2005: Günter Christ; Mariam Nikfardjam; Renate Huber-Beckmann; Michael Gottsauner-Wolf; Dietmar Glogar; Bernd R Binder; Johann Wojta; Kurt Huber
Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Journal of thrombosis and haemostasis : JTH 2005;3(2):233-9.
2005: Rudolf Jarai; Nelly Iordanova; Robert Jarai; Annamaria Raffetseder; Wolfgang Woloszczuk; Mariann Gyöngyösi; Georg Geyer; Johann Wojta; Kurt Huber
Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
European heart journal 2005;26(3):250-6.
2005: Walter S Speidl; Andrea Zeiner; Mariam Nikfardjam; Alexander Geppert; Nelli Jordanova; Alexander Niessner; Gerlinde Zorn; Gerald Maurer; Wolfgang Schreiber; Johann Wojta; Kurt Huber
An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Journal of the American College of Cardiology 2005;45(1):30-4.
2005: Stefan Pfaffenberger; Branka Devcic-Kuhar; Christian Kollmann; Stefan Kastl; Christoph Kaun; Walter S Speidl; Thomas Weiss; Svitlana Demyanets; Robert Ullrich; Heinz Sochor; Christian Wöber; Josef Zeitlhofer; Kurt Huber; Martin Gröschl; Ewald Benes; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.
Stroke; a journal of cerebral circulation 2005;36(1):124-8.
2004: Mitsuhiro Uchiba; Kenji Okajima; Christoph Kaun; Johann Wojta; Bernd R Binder
Inhibition of the endothelial cell activation by antithrombin in vitro.
Thrombosis and haemostasis 2004;92(6):1420-7.
2004: Mariann Gyöngyösi; Hans Domanovits; Werner Benzer; Moritz Haugk; Birgit Heinisch; Gottfried Sodeck; Ronald Hödl; Georg Gaul; Gerhard Bonner; Johann Wojta; Anton N Laggner; Dietmar Glogar; Kurt Huber
Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
European heart journal 2004;25(23):2125-33.
2004: Marion Funk; Georg Endler; Renate Freitag; Johann Wojta; Kurt Huber; Christine Mannhalter; Raute Sunder-Plassmann
CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.
Clinical chemistry 2004;50(12):2395-8.
2004: Branka Devcic-Kuhar; Stefan Pfaffenberger; Lisa Gherardini; Christoph Mayer; Martin Gröschl; Christoph Kaun; Ewald Benes; Erwin Tschachler; Kurt Huber; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro.
Thrombosis and haemostasis 2004;92(5):980-5.
2004: Alexander Niessner; Stephan Hornykewycz; Senta Graf; Mariam Nikfardjam; Walter S Speidl; Peter Probst; Gerlinde Zorn; Gerald Maurer; Johann Wojta; Kurt Huber
Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(4):311-6.
2004: Johannes Pammer; Christine Reinisch; Christoph Kaun; Erwin Tschachler; Johann Wojta
Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
Endothelium : journal of endothelial cell research 2004;11(3-4):175-80.
2004: Thomas Weiss; Mohammad Reza Mehrabi; Christoph Kaun; Gerlinde Zorn; Stefan Kastl; Walter S Speidl; Stefan Pfaffenberger; Gersina Rega; Helmut D Glogar; Gerald Maurer; Richard Pacher; Kurt Huber; Johann Wojta
Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism.
Journal of molecular and cellular cardiology 2004;36(4):539-46.
2004: Walter S Speidl; Wolfgang Toller; Christoph Kaun; Thomas Weiss; Stefan Pfaffenberger; Stefan Kastl; Alexander Furnkranz; Gerald Maurer; Kurt Huber; Helfried Metzler; Johann Wojta
Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(3):603-5.
2004: Christoph W Kopp; Thomas Hölzenbein; Sabine Steiner; Rodrig Marculescu; Helga Bergmeister; Daniela Seidinger; Isabella Mosberger; Christoph Kaun; Manfred Cejna; Reinhard Horvat; Johann Wojta; Gerald Maurer; Bernd R Binder; Johannes M Breuss; Rupert C Ecker; Rainer de Martin; Erich Minar
Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.
Blood 2004;103(5):1653-61.
2004: Georg Endler; Markus Exner; Martin Schillinger; Rodrig Marculescu; Raute Sunder-Plassmann; Marianne Raith; Nelli Jordanova; Johann Wojta; Christine Mannhalter; Oswald F Wagner; Kurt Huber
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease.
Thrombosis and haemostasis 2004;91(1):155-61.
2004: Mariann Gyöngyösi; Dietmar Glogar; Franz Weidinger; Hans Domanovits; Anton N Laggner; Johann Wojta; Gerlinde Zorn; Nelly Iordanova; Kurt Huber
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
American heart journal 2004;147(1):158-64.
2003: Wei-Jian Zhang; Peter Hufnagl; Bernd R Binder; Johann Wojta
Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression.
Thrombosis and haemostasis 2003;90(5):904-14.
2003: Marisa Gallicchio; Christoph Kaun; Johann Wojta; Bernd Binder; Leon A Bach
Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Journal of cellular physiology 2003;197(1):131-8.
2003: Romana Schäfer; Dietmar Abraham; Patrick Paulus; Roland Blumer; Michael Grimm; Johann Wojta; Seyedhossein Aharinejad
Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Circulation 2003;108(13):1585-91.
2003: Johann Wojta; Kurt Huber; Peter Valent
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):438-41.
2003: Thomas Weiss; Walter S Speidl; Christoph Kaun; Gersina Rega; Christopher Springer; Karin Macfelda; Udo M Losert; Susan L Grant; Martin L Marro; Andrew D Rhodes; Alexander Fuernkranz; Jan Bialy; Robert Ullrich; Philipp Holzmann; Richard Pacher; Gerald Maurer; Kurt Huber; Johann Wojta
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Cardiovascular research 2003;59(3):628-38.
2003: Alexander Niessner; Senta Graf; Mariam Nikfardjam; Walter S Speidl; Renate Huber-Beckmann; Gerlinde Zorn; Johann Wojta; Kurt Huber
Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
Thrombosis and haemostasis 2003;90(2):344-50.
2003: Alexander Niessner; Christoph Kaun; Gerlinde Zorn; Walter S Speidl; Zeynep Türel; Gunna Christiansen; Anna Sofie Pedersen; Svend Birkelund; Susan Simon; Apostolos Georgopoulos; Wolfgang Graninger; Rainer de Martin; Joachim Lipp; Bernd R Binder; Gerald Maurer; Kurt Huber; Johann Wojta
Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway.
The Journal of infectious diseases 2003;188(1):108-13.
2003: Georg Endler; Ahmad Hamwi; Raute Sunder-Plassmann; Markus Exner; Thomas Vukovich; Christine Mannhalter; Johann Wojta; Kurt Huber; Oswald Wagner
Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?
Clinical chemistry 2003;49(7):1201-4.
2003: Mitsuhiro Uchiba; Kenji Okajima; Christoph Kaun; Bernd R Binder; Johann Wojta
Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
Critical care medicine 2003;31(4):1147-53.
2003: Stefan Pfaffenberger; Branka Devcic-Kuhar; Karem El-Rabadi; Martin Gröschl; Walter S Speidl; Thomas Weiss; Kurt Huber; Ewald Benes; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves.
Thrombosis and haemostasis 2003;89(3):583-9.
2003: Georg Endler; Markus Exner; Marianne Raith; Rodrig Marculescu; Christine Mannhalter; Lukas Endler; Johann Wojta; Kurt Huber; Oswald F Wagner
The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.
Thrombosis research 2003;112(1-2):47-50.
2003: Ansgar Weltermann; Peter Fritsch; Paul A Kyrle; Verena Schoenauer; Georg Heinze; Johann Wojta; Günter Christ; Kurt Huber
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
Thrombosis research 2003;112(1-2):19-24.
2002: Karin Macfelda; Thomas Weiss; Christoph Kaun; Johannes M Breuss; Gerlinde Zorn; Ulrich Oberndorfer; Margit Voegele-Kadletz; Renate Huber-Beckmann; Robert Ullrich; Bernd R Binder; Udo M Losert; Gerald Maurer; Richard Pacher; Kurt Huber; Johann Wojta
Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
Journal of molecular and cellular cardiology 2002;34(12):1681-91.
2002: Manfred Prager; Zeynep Türel; Walter S Speidl; Gerlinde Zorn; Christoph Kaun; Alexander Niessner; Georg Heinze; Ihor Huk; Gerald Maurer; Kurt Huber; Johann Wojta
Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.
Stroke; a journal of cerebral circulation 2002;33(12):2756-61.
2002: Mohammad Reza Mehrabi; Nermin Serbecic; Forouzan Tamaddon; Christoph Kaun; Kurt Huber; Richard Pacher; Thomas Wild; Gerhard Mall; Johann Wojta; Helmut D Glogar
Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.
Cardiovascular research 2002;56(2):214-24.
2002: Mohammad Reza Mehrabi; Kurt Huber; Nermin Serbecic; Thomas Wild; Johann Wojta; Forouzan Tamaddon; Abdelmonem Morgan; Robert Ullrich; Helmut Dietmar Glogar
Elevated homocysteine serum level is associated with low enrichment of homocysteine in coronary arteries of patients with coronary artery disease.
Thrombosis research 2002;107(5):189-96.
2002: Walter S Speidl; Senta Graf; Stephan Hornykewycz; Mariam Nikfardjam; Alexander Niessner; Gerlinde Zorn; Johann Wojta; Kurt Huber
High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease.
American heart journal 2002;144(3):449-55.
2002: Johann Wojta; Christoph Kaun; Gerlinde Zorn; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Gerhard Fritsch; Dieter Printz; Bernd R Binder; Georg Schatzl; Jörg Zwirner; Gerald Maurer; Kurt Huber; Peter Valent
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.
Blood 2002;100(2):517-23.
2002: Peter Valent; Mehrdad Baghestanian; Hans C Bankl; Christian Sillaber; Wolfgang R Sperr; Johann Wojta; Bernd R Binder; Klaus Lechner
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
Thrombosis and haemostasis 2002;87(5):786-90.
2002: Franz Wiesbauer; Christoph Kaun; Gerlinde Zorn; Gerald Maurer; Kurt Huber; Johann Wojta
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
British journal of pharmacology 2002;135(1):284-92.
2001: Mariam Nikfardjam; Senta Graf; Stephan Hornykewycz; Gerlinde Zorn; Renate Huber-Beckmann; Johann Wojta; Kurt Huber
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
Thrombosis research 2001;103 Suppl 1():S35-9.
2001: Kurt Huber; Günter Christ; Johann Wojta; D Gulba
Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.
Thrombosis research 2001;103 Suppl 1():S7-19.
2001: Anahit Anvari; Ernst Schuster; Michael Gottsauner-Wolf; Johann Wojta; Kurt Huber
PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease.
Thrombosis research 2001;103(2):103-7.
2001: Q R Ruan; Wei-Jian Zhang; Peter Hufnagl; Christoph Kaun; Bernd R Binder; Johann Wojta
Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
Journal of vascular research 2001;38(1):13-9.
2000: Regina E Roller; S Janisch; E Kvas; Wolfgang J Schnedl; Bernd R Binder; Johann Wojta; C Korninger
Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty.
Thrombosis and haemostasis 2000;84(6):1113-6.
2000: Michael Gottsauner-Wolf; Paul Wexberg; Karem El-Rabadi; Johann Wojta; Gerald Maurer; Kurt Huber
[Atherosclerosis: an infectious disease?].
Wiener klinische Wochenschrift 2000;112(6):253-9.
1999: Johannes Pammer; Wolfgang Weninger; Jozef Ban; Johann Wojta; Erwin Tschachler
The cell death regulatory protein bak is expressed in endothelial cells in inflamed tissues and Is induced by IFN-gamma in vitro.
Biochemical and biophysical research communications 1999;264(1):139-43.
1999: A Obermair; Andreas Obruca; Michaela Pöhl; A Kaider; Anja Vales; Sepp Leodolter; Johann Wojta; Wilfried Feichtinger
Vascular endothelial growth factor and its receptors in male fertility.
Fertility and sterility 1999;72(2):269-75.
1999: Michael Krebs; Pavel Uhrin; Anja Vales; M J Prendes-Garcia; Johann Wojta; Margarethe Geiger; Bernd R Binder
Protein C inhibitor is expressed in keratinocytes of human skin.
The Journal of investigative dermatology 1999;113(1):32-7.
1999: Regina E Roller; S Janisch; VA Carroll; E Kvas; Ernst Pilger; Bernd R Binder; Johann Wojta
Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.
Thrombosis research 1999;94(4):241-7.
1999: Johann Wojta; Christoph Kaun; Johannes M Breuss; Yuri Koshelnick; R Beckmann; E Hattey; Michael Mildner; Wolfgang Weninger; T Nakamura; Erwin Tschachler; Bernd R Binder
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
Laboratory investigation; a journal of technical methods and pathology 1999;79(4):427-38.
1999: J C Zhang; Q Ruan; L Paucz; A Fabry; Bernd R Binder; Johann Wojta
Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro.
Journal of vascular research 1999;36(2):126-32.
1998: Johannes Pammer; Wolfgang Weninger; Michael Mildner; Martin Burian; Johann Wojta; Erwin Tschachler
Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals.
The Journal of pathology 1998;186(2):186-91.
1997: Walter Tschugguel; Zyhdi Zhegu; Christian Schneeberger; E Tantscher; Klaus Czerwenka; A Fabry; Johann Wojta; R Zeillinger; Johannes C Huber
Estrogen does not induce the calcium-dependent nitric oxide synthase in cultured human uterine endothelial and myometrial smooth muscle cells.
Journal of vascular research 1997;34(4):281-8.
1997: Wei-Jian Zhang; Johann Wojta; Bernd R Binder
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Journal of vascular research 1997;34(4):273-80.
1997: Wei-Jian Zhang; Johann Wojta; Bernd R Binder
Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.
Cellular and molecular biology (Noisy-le-Grand, France) 1997;43(4):581-7.
1997: Günter Christ; Peter Hufnagl; Christoph Kaun; Gerald Mundigler; Günther Laufer; Kurt Huber; Johann Wojta; Bernd R Binder
Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):723-30.
1997: Wei-Jian Zhang; Johann Wojta; Bernd R Binder
Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(3):465-74.
1997: Mehrdad Baghestanian; R Hofbauer; Hans Georg Kress; Johann Wojta; A Fabry; Bernd R Binder; Christoph Kaun; Martin R Müller; Mohammad Reza Mehrabi; Stylianos Kapiotis; Gürkan Sengoelge; Minoo Ghannadan; Klaus Lechner; Peter Valent
Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF.
Thrombosis and haemostasis 1997;77(3):577-84.
1996: J C Zhang; A Fabry; L Paucz; Johann Wojta; Bernd R Binder
Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells.
Blood 1996;88(10):3880-6.
1996: Hans Zoellner; M Höfler; R Beckmann; P Hufnagl; E Vanyek; Edith Bielek; Johann Wojta; A Fabry; S Lockie; Bernd R Binder
Serum albumin is a specific inhibitor of apoptosis in human endothelial cells.
Journal of cell science 1996;109 ( Pt 10)():2571-80.
1996: Marisa Gallicchio; P Hufnagl; Johann Wojta; Peter G Tipping
IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(6):2610-7.
1995: J C Zhang; Johann Wojta; Bernd R Binder
Growth and fibrinolytic parameters of human umbilical vein endothelial cells seeded onto cardiovascular grafts.
The Journal of thoracic and cardiovascular surgery 1995;109(6):1059-65.
1994: D B al-Azhary; Johann Wojta; Bernd R Binder
Fibrinolytic system of cultured rabbit aortic endothelial cells.
Thrombosis research 1994;75(5):559-68.
1994: Ian K Campbell; Johann Wojta; Ulrike Novak; John A Hamilton
Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
Biochimica et biophysica acta 1994;1226(3):277-85.
1994: Wei-Jian Zhang; Johann Wojta; Bernd R Binder
Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1040-6.
1994: Johann Wojta; T Nakamura; A Fabry; P Hufnagl; R Beckmann; K McGrath; Bernd R Binder
Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
Blood 1994;84(1):151-7.
1994: Marisa Gallicchio; S Argyriou; G Ianches; E L Filonzi; Hans Zoellner; John A Hamilton; K McGrath; Johann Wojta
Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(5):815-23.
1994: Johann Wojta; Hans Zoellner; Marisa Gallicchio; E L Filonzi; John A Hamilton; K McGrath
Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Lymphokine and cytokine research 1994;13(2):133-8.
1994: JJ Liu; D Casley; Johann Wojta; Marisa Gallicchio; R Dauer; C I Johnston; B F Buxton
Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Clinical and experimental pharmacology & physiology 1994;21(1):49-57.
1993: John A Hamilton; Genevieve A Whitty; H Stanton; Johann Wojta; M Gallichio; K McGrath; G Ianches
Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes.
Blood 1993;82(12):3616-21.
1993: John A Hamilton; Johann Wojta; M Gallichio; K McGrath; E L Filonzi
Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(10):5154-61.
1993: John A Hamilton; Genevieve A Whitty; Johann Wojta; M Gallichio; K McGrath; G Ianches
Regulation of plasminogen activator inhibitor-1 levels in human monocytes.
Cellular immunology 1993;152(1):7-17.
1993: Johann Wojta; Marisa Gallicchio; Hans Zoellner; P Hufnagl; Karena Last; E L Filonzi; Bernd R Binder; John A Hamilton; K McGrath
Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Thrombosis and haemostasis 1993;70(3):469-74.
1993: JJ Liu; D Casley; Johann Wojta; Marisa Gallicchio; R Dauer; B F Buxton; C I Johnston
Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells.
Journal of hypertension 1993;11(9):977-82.
1993: Johann Wojta; Marisa Gallicchio; Hans Zoellner; E L Filonzi; John A Hamilton; K McGrath
Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells.
Blood 1993;81(12):3285-92.
1993: G Christ; D Seiffert; P Hufnagl; Alois Gessl; Johann Wojta; Bernd R Binder
Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells.
Blood 1993;81(5):1277-83.
1993: Hans Zoellner; Johann Wojta; Marisa Gallicchio; K McGrath; John A Hamilton
Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis.
Thrombosis and haemostasis 1993;69(2):135-40.
1992: John A Hamilton; Ian K Campbell; Johann Wojta; D Cheung
Plasminogen activators and their inhibitors in arthritic disease.
Annals of the New York Academy of Sciences 1992;667():87-100.
1992: John A Hamilton; D Cheung; E L Filonzi; D S Piccoli; Johann Wojta; M Gallichio; K McGrath; Karena Last
Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.
Arthritis and rheumatism 1992;35(12):1526-34.
1992: Johann Wojta; Hans Zoellner; Marisa Gallicchio; John A Hamilton; K McGrath
Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro.
Biochemical and biophysical research communications 1992;188(1):463-9.
1992: Oswald F Wagner; G Christ; Johann Wojta; Heinrich Vierhapper; S Parzer; Peter Nowotny; B Schneider; Werner Waldhäusl; Bernd R Binder
Polar secretion of endothelin-1 by cultured endothelial cells.
The Journal of biological chemistry 1992;267(23):16066-8.
1989: Margarethe Geiger; K Huber; Johann Wojta; L Stingl; F Espana; J H Griffin; Bernd R Binder
Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
Blood 1989;74(2):722-8.
1989: J C Kirchheimer; Johann Wojta; Günter Christ; Bernd R Binder
Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5424-8.
1989: Johann Wojta; R Beckmann; L Turcu; Oswald F Wagner; A J van Zonneveld; Bernd R Binder
Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
The Journal of biological chemistry 1989;264(14):7957-61.
1988: Kurt Huber; Johann Wojta; J C Kirchheimer; D Ermler; Bernd R Binder
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid.
European journal of clinical investigation 1988;18(6):595-9.
1988: J C Kirchheimer; Johann Wojta; Günter Christ; G Hienert; Bernd R Binder
Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells.
Carcinogenesis 1988;9(11):2121-3.
1988: K Bartha; Johann Wojta; Oswald F Wagner; Bernd R Binder
Comparison of fibrinolytic activities of human and bovine endothelial cells.
The American journal of physiology 1988;254(6 Pt 2):R885-90.
1988: Johann Wojta; J C Kirchheimer; M G Peska; B R Binder
Effect of caffein ingestion on plasma fibrinolytic potential.
Thrombosis and haemostasis 1988;59(2):337-8.
1988: F Ehrenreich; E Hattey; Johann Wojta; Bernd R Binder
Effect of anti plasminogen monoclonal antibodies on whole blood clot lysis.
Haemostasis 1988;18 Suppl 1():99-107.
1987: J C Kirchheimer; Johann Wojta; G Hienert; Günter Christ; M E Heger; H Pflüger; Bernd R Binder
Effect of urokinase on the proliferation of primary cultures of human prostatic cells.
Thrombosis research 1987;48(3):291-8.
1987: Wolfgang Speiser; Johann Wojta; C Korninger; J C Kirchheimer; J Zazgornik; Bernd R Binder
Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis.
Kidney international 1987;32(2):280-3.
1987: J C Kirchheimer; Johann Wojta; Günter Christ; B R Binder
Proliferation of a human epidermal tumor cell line stimulated by urokinase.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1987;1(2):125-8.
1987: J C Kirchheimer; I Resch; Günter Christ; Johann Wojta; B R Binder
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
European journal of biochemistry / FEBS 1987;166(2):393-7.
1987: Johann Wojta; L Turcu; Oswald F Wagner; C Korninger; Bernd R Binder
Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
The Journal of laboratory and clinical medicine 1987;109(6):665-71.
1987: E Hattey; Johann Wojta; Bernd R Binder
Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigens.
Thrombosis research 1987;45(5):485-95.
1986: Johann Wojta; J C Kirchheimer; L Turcu; Günter Christ; Bernd R Binder
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
Thrombosis and haemostasis 1986;55(3):347-51.
1986: C Korninger; Wolfgang Speiser; Johann Wojta; B R Binder
Sandwich ELISA for t-PA antigen employing a monoclonal antibody.
Thrombosis research 1986;41(4):527-35.
1985: Johann Wojta; C Korninger; J Kirchheimer; E Hattey; L Turcu; Bernd R Binder
[Use of monoclonal antibodies in the diagnosis of fibrinolysis].
Wiener klinische Wochenschrift 1985;97(5):244-8.